Ethereum and XRP Price Momentum Fades While AlphaPepe Dominates As Best Crypto to Invest in April...

The ceasefire rally faded. Capital Street FX’s April 10 daily report confirmed it in numbers: Ethereum at $2,187 down 1.03%, XRP at $1.3449 down 0.87%. The momentum that the ceasefire briefly created lasted hours before the underlying conditions reasserted themselves. XRP has now posted six consecutive monthly losses since October 2025. ETH keeps getting rejected at $2,200.

When established asset momentum fades, AlphaPepe Stage 12 keeps filling. Over $800,000 raised. Stage 11 sold out. $0.01422. Q2 approaching.

Six Monthly XRP Losses and an ETH Level That Keeps Getting Rejected

The pattern of fading momentum across ETH and XRP is not random. Both assets are in a cycle phase where brief windows of optimism, a ceasefire, a Senate return, a strong ETF inflow week, open and close faster than the underlying macro conditions resolve. CoinDesk confirmed XRP edges higher to $1.35 on a breakout but bullish momentum still lacks, with analysts flagging potential downside if the strength does not find structural support. Seeking Alpha confirmed the positive momentum that drove XRP’s strong inflow week faded later in the same seven days.

Ethereum’s fight for $2,200 tells the same story from a different asset. The ceasefire briefly pushed ETH to $2,254. The doubt sessions that followed pulled it back toward $2,150. The cup and handle targeting $3,000 is forming on the weekly chart. The Glamsterdam upgrade arrives in May or June. Every constructive signal builds and then stalls before confirming. The momentum is real when it appears. It is just not durable enough to hold through any contested macro session.

Why AlphaPepe’s Momentum Runs on a Different Clock

Not Launched on DEX Yet. Stage 11 Sold Out. Over $800,000 Raised. Stage 12 at $0.01422.

AlphaSwap generates real cross-chain trading fee revenue whether ETH holds $2,200 or gives it back. The AI DEX demo dropping this week is the timestamped public confirmation of infrastructure that has been running before any exchange has listed the token. That is the structural difference between a product whose momentum depends on geopolitical news and one whose momentum depends on a DEX processing actual swaps.

AlphaPepe is at $0.01422 in Stage 12 with over $800,000 raised from 7,500+ holders and 100 new wallets entering daily. The developer was a member of the Shibarium team at Shiba Inu, an operation that processed over 500 million mainnet transactions, before building AlphaSwap. A 10/10 BlockSAFU audit was completed before the presale opened to the public. Tokens arrive in your wallet instantly at purchase with no vesting period attached. Staking runs at 85% APR from day one. Code ALPHA50 adds 50% to the token allocation for entries at $2,000 or more.

At $0.01422 a $2,000 entry produces 140,646 tokens. With ALPHA50 that becomes 210,969 tokens worth around $316,454 at $1.50 and $738,392 at $3.50 ahead of the Tier 1 CEX debut. ETH and XRP momentum fades when the macro does. AlphaPepe runs on the clock that says Q2.

Join the AlphaPepe presale before Stage 12 sells out.

FAQs

Why does ETH and XRP price momentum fade in April 2026?ETH dropped 1.03% and XRP dropped 0.87% on April 10 as the ceasefire rally faded, with XRP posting six consecutive monthly losses since October 2025 and CoinDesk confirming bullish momentum still lacks structural support despite brief breakout attempts at $1.35.

What could a $2,000 Stage 12 entry with ALPHA50 be worth at Q2 launch?At $0.01422 with ALPHA50 a $2,000 entry produces 210,969 tokens worth around $316,454 at $1.50 and $738,392 at the $3.50 Tier 1 projection.

Why does AlphaPepe dominate as best crypto to invest in April 2026 while ETH and XRP momentum fades?AlphaSwap generates real trading fee revenue through every session regardless of macro sentiment, with over $800,000 raised and Stage 11 sold out confirming accumulation driven by product quality rather than geopolitical momentum that fades within 48 hours of any ceasefire being contested.

This article is not intended as financial advice. Educational purposes only.